We’ve scanned the newsfeeds of all the important marijuana stocks and put together this recap to save you the time and hassle.
Top News Stories for Tuesday, September 10, 2019:
Harvest One Cannabis (TSXV: HVT) (OTCQX: HRVOF), through its wholly-owned subsidiary United Greeneries announces that, on September 6, 2019, it obtained an amendment to its licence from Health Canada which will allow for the sale of cannabis oil products.
Receiving a cannabis oil sales licence from Health Canada is a significant milestone for Harvest One as we prepare formulations for the next wave of cannabis products in Canada.
Canopy Rivers (TSX: RIV) (OTCPK: CNPOF) is pleased to share that its portfolio company Herbert Works has received its research and development (R&D) licence from Health Canada to develop branded cannabis-infused beverages.
“This announcement represents a significant milestone for Herbert Works as the company continues to move quickly toward the development of exceptional and widely appealing THC-infused beverages,” said Narbe Alexandrian, President and CEO of Canopy Rivers.
Zenabis Global (TSX: ZENA) (OTCPK: ZBISF) today announced that it has entered into a Supply Agreement with the Ontario Cannabis Retail Corporation (“OCS”) to supply adult-use recreational cannabis to retailers throughout the province.
Zenabis will begin supplying OCS with 21 distinct, adult-use cannabis products under its premium Namaste and Blazery brands, in the third quarter of 2019.
Valens GroWorks (TSXV: VGW) (OTCQX: VGWCF) is pleased to announce revenue guidance for the recently completed third quarter 2019 in the range of $16 million – $17 million, a significant increase over its second quarter 2019 revenue of $8.8 million.
Jeffrey Fallows, President, said “We continue to see a significant ramp up in volumes month over month with August seeing almost 50% of the volumes in the third quarter. That pace has continued to accelerate into September as we look to fill our existing capacity on a run-rate basis in the next 6 months.”
Heritage Cannabis (CSE: CANN) (OTCQX: HERTF) is pleased to announce that it has entered into two Agreements with Weed Me Inc. to purchase a bulk order of cannabis biomass, and a ‘right of first offer’ (ROFO) to secure future cannabis supply.
“We are please to have Weed Me as a contracted supplier of cannabis biomass. Their ability to grow quality THC and CBD content cannabis which meets our high specifications contributes to our increased production schedule to meet our customer’s product expansion plans,” says Clint Sharples, CEO of Heritage.
1933 Industries (CSE: TGIF) (OTCQX: TGIFF) announces the execution of a Licensing Agreement for the launch of Blonde™, a high-end California brand making its debut in Nevada.
Under the terms of the one-year agreement, Alternative Medicine Association (AMA), a 91% owned subsidiary of the Company, receives the exclusive rights to cultivate flower, manufacture pre-rolls, live resin vape pens and cartridges under the Blonde™ brand for distribution to licensed dispensaries throughout Nevada.
MedMen (CSE: MMEN) (OTCQX: MMNFF) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR Act), has expired with respect to the proposed acquisition of PharmaCann, LLC.
“Today marks a monumental day for the cannabis industry,” said Adam Bierman, MedMen co-founder and chief executive officer. “We hope this will pave the way for other companies in what has become a highly acquisitive and dynamic industry.”
Village Farms (TSX: VFF) (NASDAQ: VFF) today announced Michael DeGiglio, Chief Executive Officer, will present at the Scotiabank Cannabis Company Forum on September 12, 2019 in Sydney, Australia.
Village Farms is one of five North American-listed companies being showcased by Scotiabank to Australian institutional investors at this event.
AXIM® Biotechnologies (OTCQB: AXIM), a world leader in cannabinoid research and development, announced today that its contract manufacturer Eurofins Amatsigroup has begun manufacturing AXIM’s patented cannabinoid-based chewing gum with dronabinol, a synthetic form of tetrahydrocannabinol (THC), for use in the Company’s upcoming clinical studies on cannabis as a treatment for chemotherapy related symptoms.
“We are excited to get started on manufacturing our gum containing dronabinol and proving that our unique delivery method can provide cancer patients with quicker and more efficient relief from their chemotherapy related symptoms,” said John W. Huemoeller II, Chief Executive Officer of AXIM® Biotech.
Trulieve Cannabis (CSE: TRUL) (OTCQX: TCNNF) today announced the hiring of two new members to its leadership team.
“We are pleased to have Chris and Chloe join our team at Trulieve as they bring proven track records of success across a range of industries,” said Kim Rivers, CEO of Trulieve.
Move Over Curaleaf, There’s a New MSO in Town and it’s Set to Hit The Street This September
Get the full details here so you don’t miss out on the next potential 10 bagger.